Factors associated with the contraindicated use of oral contraceptives in Brazil

Detalhes bibliográficos
Autor(a) principal: Corrêa,Daniele Aparecida Silva
Data de Publicação: 2017
Outros Autores: Felisbino-Mendes,Mariana Santos, Mendes,Mayara Santos, Malta,Deborah Carvalho, Velasquez-Melendez,Gustavo
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Revista de Saúde Pública
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0034-89102017000100201
Resumo: ABSTRACT OBJECTIVE To estimate the prevalence of the contraindicated use of oral contraceptives and the associated factors in Brazilian women. METHODS 20,454 women who answered the VIGITEL survey in 2008 also participated in this study, of which 3,985 reported using oral contraceptives. We defined the following conditions for the contraindicated use of contraceptives: hypertension; cardiovascular diseases such as heart attack, stroke/cerebrovascular accident; diabetes mellitus; being smoker and 35 years old or older. We estimated the prevalence and 95% confidence intervals of contraindicated use in users of oral contraceptives and the factors associated with contraindication by prevalence ratio and 95% confidence intervals. RESULTS In the total population, 21% (95%CI 19.7–21.9) of women showed some contraindication to the use of oral contraceptives, of which 11.7% (95%CI 10.6–13.7) belonged to the group of users of oral contraceptives. The most frequent contraindication in users of oral contraceptives was hypertension (9.1%). The largest proportion of women with at least one contraindication was aged between 45 and 49 years (45.8%) and with education level between zero and eight years (23.8%). The prevalence of contraindication to oral contraceptives was higher in women less educated (zero to eight years of study) (PR = 2.46; 95%CI 1.57–3.86; p < 0.05) and with age between 35-44 years (PR = 4.00; 95%CI 2.34–6.83) and 45-49 years (PR = 5.59; 95%CI 2.90–10.75). CONCLUSIONS Age greater than or equal to 35 and low education level were demographic and iniquity factors, respectively, in the contraindicated use of oral contraceptives.
id USP-23_6bd0b30eba928b27fd71ce4b6cd5aee3
oai_identifier_str oai:scielo:S0034-89102017000100201
network_acronym_str USP-23
network_name_str Revista de Saúde Pública
repository_id_str
spelling Factors associated with the contraindicated use of oral contraceptives in BrazilContraceptives, Oral, contraindicationsPrescription Drug MisuseRisk FactorsWomen’s HealthSexual and Reproductive HealthABSTRACT OBJECTIVE To estimate the prevalence of the contraindicated use of oral contraceptives and the associated factors in Brazilian women. METHODS 20,454 women who answered the VIGITEL survey in 2008 also participated in this study, of which 3,985 reported using oral contraceptives. We defined the following conditions for the contraindicated use of contraceptives: hypertension; cardiovascular diseases such as heart attack, stroke/cerebrovascular accident; diabetes mellitus; being smoker and 35 years old or older. We estimated the prevalence and 95% confidence intervals of contraindicated use in users of oral contraceptives and the factors associated with contraindication by prevalence ratio and 95% confidence intervals. RESULTS In the total population, 21% (95%CI 19.7–21.9) of women showed some contraindication to the use of oral contraceptives, of which 11.7% (95%CI 10.6–13.7) belonged to the group of users of oral contraceptives. The most frequent contraindication in users of oral contraceptives was hypertension (9.1%). The largest proportion of women with at least one contraindication was aged between 45 and 49 years (45.8%) and with education level between zero and eight years (23.8%). The prevalence of contraindication to oral contraceptives was higher in women less educated (zero to eight years of study) (PR = 2.46; 95%CI 1.57–3.86; p < 0.05) and with age between 35-44 years (PR = 4.00; 95%CI 2.34–6.83) and 45-49 years (PR = 5.59; 95%CI 2.90–10.75). CONCLUSIONS Age greater than or equal to 35 and low education level were demographic and iniquity factors, respectively, in the contraindicated use of oral contraceptives.Faculdade de Saúde Pública da Universidade de São Paulo2017-01-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0034-89102017000100201Revista de Saúde Pública v.51 2017reponame:Revista de Saúde Públicainstname:Universidade de São Paulo (USP)instacron:USP10.1590/s1518-8787.2017051006113info:eu-repo/semantics/openAccessCorrêa,Daniele Aparecida SilvaFelisbino-Mendes,Mariana SantosMendes,Mayara SantosMalta,Deborah CarvalhoVelasquez-Melendez,Gustavoeng2017-01-17T00:00:00Zoai:scielo:S0034-89102017000100201Revistahttp://www.scielo.br/scielo.php?script=sci_serial&pid=0034-8910&lng=pt&nrm=isoONGhttps://old.scielo.br/oai/scielo-oai.phprevsp@org.usp.br||revsp1@usp.br1518-87870034-8910opendoar:2017-01-17T00:00Revista de Saúde Pública - Universidade de São Paulo (USP)false
dc.title.none.fl_str_mv Factors associated with the contraindicated use of oral contraceptives in Brazil
title Factors associated with the contraindicated use of oral contraceptives in Brazil
spellingShingle Factors associated with the contraindicated use of oral contraceptives in Brazil
Corrêa,Daniele Aparecida Silva
Contraceptives, Oral, contraindications
Prescription Drug Misuse
Risk Factors
Women’s Health
Sexual and Reproductive Health
title_short Factors associated with the contraindicated use of oral contraceptives in Brazil
title_full Factors associated with the contraindicated use of oral contraceptives in Brazil
title_fullStr Factors associated with the contraindicated use of oral contraceptives in Brazil
title_full_unstemmed Factors associated with the contraindicated use of oral contraceptives in Brazil
title_sort Factors associated with the contraindicated use of oral contraceptives in Brazil
author Corrêa,Daniele Aparecida Silva
author_facet Corrêa,Daniele Aparecida Silva
Felisbino-Mendes,Mariana Santos
Mendes,Mayara Santos
Malta,Deborah Carvalho
Velasquez-Melendez,Gustavo
author_role author
author2 Felisbino-Mendes,Mariana Santos
Mendes,Mayara Santos
Malta,Deborah Carvalho
Velasquez-Melendez,Gustavo
author2_role author
author
author
author
dc.contributor.author.fl_str_mv Corrêa,Daniele Aparecida Silva
Felisbino-Mendes,Mariana Santos
Mendes,Mayara Santos
Malta,Deborah Carvalho
Velasquez-Melendez,Gustavo
dc.subject.por.fl_str_mv Contraceptives, Oral, contraindications
Prescription Drug Misuse
Risk Factors
Women’s Health
Sexual and Reproductive Health
topic Contraceptives, Oral, contraindications
Prescription Drug Misuse
Risk Factors
Women’s Health
Sexual and Reproductive Health
description ABSTRACT OBJECTIVE To estimate the prevalence of the contraindicated use of oral contraceptives and the associated factors in Brazilian women. METHODS 20,454 women who answered the VIGITEL survey in 2008 also participated in this study, of which 3,985 reported using oral contraceptives. We defined the following conditions for the contraindicated use of contraceptives: hypertension; cardiovascular diseases such as heart attack, stroke/cerebrovascular accident; diabetes mellitus; being smoker and 35 years old or older. We estimated the prevalence and 95% confidence intervals of contraindicated use in users of oral contraceptives and the factors associated with contraindication by prevalence ratio and 95% confidence intervals. RESULTS In the total population, 21% (95%CI 19.7–21.9) of women showed some contraindication to the use of oral contraceptives, of which 11.7% (95%CI 10.6–13.7) belonged to the group of users of oral contraceptives. The most frequent contraindication in users of oral contraceptives was hypertension (9.1%). The largest proportion of women with at least one contraindication was aged between 45 and 49 years (45.8%) and with education level between zero and eight years (23.8%). The prevalence of contraindication to oral contraceptives was higher in women less educated (zero to eight years of study) (PR = 2.46; 95%CI 1.57–3.86; p < 0.05) and with age between 35-44 years (PR = 4.00; 95%CI 2.34–6.83) and 45-49 years (PR = 5.59; 95%CI 2.90–10.75). CONCLUSIONS Age greater than or equal to 35 and low education level were demographic and iniquity factors, respectively, in the contraindicated use of oral contraceptives.
publishDate 2017
dc.date.none.fl_str_mv 2017-01-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0034-89102017000100201
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0034-89102017000100201
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/s1518-8787.2017051006113
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Faculdade de Saúde Pública da Universidade de São Paulo
publisher.none.fl_str_mv Faculdade de Saúde Pública da Universidade de São Paulo
dc.source.none.fl_str_mv Revista de Saúde Pública v.51 2017
reponame:Revista de Saúde Pública
instname:Universidade de São Paulo (USP)
instacron:USP
instname_str Universidade de São Paulo (USP)
instacron_str USP
institution USP
reponame_str Revista de Saúde Pública
collection Revista de Saúde Pública
repository.name.fl_str_mv Revista de Saúde Pública - Universidade de São Paulo (USP)
repository.mail.fl_str_mv revsp@org.usp.br||revsp1@usp.br
_version_ 1748936503785947136